Diamyd’s warrant is listed for trading on First North

Diamyd Medical AB (publ.) executed a direct placement on April 18th 2008, where each issued new share was accompanied by a one year warrant with a subscription price of SEK 100. These warrants will now be listed on the market place First North.

In connection with this, Mangold Fondkommission AB assumes the role of liquidity provider for the Diamyd Medical B share as well as the warrant. In order to be able to act as liquidity provider, Mangold will borrow 4000 B shares from Diamyd Medical’s Chairman Anders Essen-Möller. The first day of trading with the warrant on First North is expected to be June 10, 2008.